Detalhe da pesquisa
1.
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Lancet
; 389(10073): 1011-1024, 2017 03 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28129987
2.
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.
JAMA Surg
; 154(11): 1038-1048, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31483448
3.
Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
Health Technol Assess
; 22(49): 1-326, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30209002